How to Get Losartan in New Jersey

What Losartan Is and Why New Jersey Doctors Prescribe It

Losartan is an angiotensin II receptor blocker approved by the FDA in 1995 for hypertension and later for diabetic nephropathy and heart failure with reduced ejection fraction. New Jersey clinicians prescribe it across all three indications because the drug has a long safety record, generic pricing that makes adherence realistic for most patients, and trial-level evidence backing its use in high-risk populations.

The LIFE trial (N=9,193, Lancet 2002) compared losartan 50 to 100 mg with atenolol 50 to 100 mg in patients with hypertension and left ventricular hypertrophy. Losartan produced a 13% relative-risk reduction in the composite endpoint of cardiovascular death, myocardial infarction, and stroke (P<0.001), with the stroke benefit driving most of the signal [1]. That data gave clinicians a reason to prefer ARBs over older beta-blocker regimens in patients who also have ECG evidence of LVH.

For diabetic nephropathy specifically, the RENAAL trial (N=1,513) showed that losartan 100 mg once daily reduced the risk of the primary composite renal endpoint (doubling of serum creatinine, end-stage renal disease, or death) by 16% versus placebo over a mean of 3.4 years [2]. That trial directly shaped the FDA label update in 2002 and is why New Jersey Medicaid includes diabetic nephropathy as a covered indication.

The drug's mechanism is straightforward. Losartan blocks the AT1 receptor, preventing angiotensin II from raising blood pressure through vasoconstriction and aldosterone release. Unlike ACE inhibitors, ARBs do not accumulate bradykinin, so cough rates are much lower and the drug is frequently the next step for patients who stop lisinopril or enalapril because of persistent cough [3].

Losartan is taken once daily, typically 50 mg to start, with the option to titrate to 100 mg if blood pressure remains above target. Some patients with volume depletion or severe hepatic impairment start at 25 mg. The FDA label recommends 25 mg as the starting dose for patients with hepatic impairment [4].

Legal Framework for Prescribing Losartan in New Jersey

New Jersey permits telehealth prescribing of non-controlled medications under N.J.S.A. 45:1-61 through 45:1-67, the New Jersey Telemedicine and Telehealth Act. A prescriber does not need to conduct an in-person physical exam before writing a losartan prescription if a synchronous audio-video encounter establishes a valid patient-provider relationship and meets the standard of care. Asynchronous (store-and-forward) encounters are permitted for some situations but synchronous video is strongly preferred for a new cardiovascular medication where baseline blood pressure reading and symptom review are relevant.

The New Jersey Division of Consumer Affairs Board of Medical Examiners has published guidance confirming that the prescribing standard of care applies equally whether the encounter is in-person or via video [5]. Prescribers must hold an active New Jersey license, and out-of-state telehealth providers treating New Jersey patients must obtain a New Jersey telemedicine registration through the Division of Consumer Affairs.

Nurse practitioners in New Jersey operate under the Advanced Practice Nurse (APN) statute (N.J.S.A. 45:11-23 et seq.). As of 2021, New Jersey APNs with more than 1 to 200 hours of supervised practice may prescribe independently without a physician collaboration agreement [6]. Physician assistants (PAs) in New Jersey may prescribe under a delegation agreement with a supervising physician. All three provider types, MD, DO, NP, and PA, can legally write a losartan prescription.

How to Get a Losartan Prescription in New Jersey: Step by Step

Getting losartan in New Jersey follows the same basic sequence whether you use a traditional office or a telehealth platform.

Step 1. Choose your care pathway. In-person primary care, cardiology, or nephrology offices remain the most common route. Telehealth platforms licensed in New Jersey handle the same visit via video and can transmit an electronic prescription directly to a New Jersey pharmacy within minutes of the appointment ending.

Step 2. Complete a medical intake. A clinician reviews your blood pressure history, current medications (especially NSAIDs, potassium supplements, or other renin-angiotensin system drugs, since combinations raise hyperkalemia risk), and any contraindications. Pregnancy is an absolute contraindication; losartan is FDA Pregnancy Category D and causes fetal harm [4].

Step 3. Order baseline labs. A basic metabolic panel confirming creatinine, blood urea nitrogen, potassium, and eGFR is standard before starting therapy. For women of childbearing age, a urine or serum pregnancy test is required. Many telehealth providers send a lab order electronically to a national draw site (LabCorp or Quest), and results return in 12 to 48 hours.

Step 4. Receive and fill the prescription. The prescriber sends an e-prescription to your preferred New Jersey pharmacy. Generic losartan is available at virtually every major chain in the state, including CVS, Walgreens, Rite Aid, ShopRite, and Walmart pharmacy, as well as independent pharmacies across Essex, Bergen, Middlesex, Mercer, and Camden counties.

Step 5. Schedule a follow-up. Most guidelines recommend rechecking blood pressure and repeating a basic metabolic panel 2 to 4 weeks after starting or titrating losartan, primarily to catch any rise in potassium or creatinine [7]. The American Heart Association's 2017 Hypertension Guideline (ACC/AHA) sets a blood pressure target of <130/80 mmHg for most adults, which will guide whether the dose needs to move from 50 mg to 100 mg [7].

Lab Requirements Before Starting Losartan in New Jersey

Labs matter before losartan starts. The most clinically meaningful pre-treatment values are serum potassium (normal 3.5 to 5.0 mEq/L), serum creatinine, and eGFR. ARBs reduce aldosterone-driven potassium excretion, so a patient who enters therapy with a potassium of 5.2 mEq/L may be at real risk for hyperkalemia, especially if they are also on a potassium-sparing diuretic like spironolactone.

The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 guidelines recommend monitoring creatinine and potassium 2 to 4 weeks after initiating or up-titrating any renin-angiotensin-aldosterone system (RAAS) blocker [8]. A creatinine rise of up to 30% above baseline is generally acceptable and may reflect the drug's desired effect of reducing glomerular hyperfiltration. Rises greater than 30% should prompt evaluation for renal artery stenosis.

For patients with diabetes (one of the NJ Medicaid-covered indications), a urine albumin-to-creatinine ratio (UACR) at baseline provides a useful reference point, since losartan's renoprotective benefit in RENAAL was most pronounced in patients with macroalbuminuria (UACR >300 mg/g) [2].

A lipid panel and hemoglobin A1c are not required before starting losartan but are often ordered at the same visit because patients presenting for blood pressure management frequently need cardiovascular risk stratification under the 2019 ACC/AHA Primary Prevention Guidelines [9].

Telehealth Providers in New Jersey Prescribing Losartan

Telehealth access for losartan in New Jersey has expanded substantially since the state's 2017 telemedicine law. Multiple national platforms, including Teladoc, MDLive, and Amazon Clinic, hold New Jersey licensing and can prescribe non-controlled antihypertensive medications after a video visit. HealthRX's own New Jersey-licensed clinical team conducts synchronous video evaluations and transmits electronic prescriptions to the patient's preferred pharmacy on the same day.

The HealthRX "Hypertension Access Framework" for New Jersey patients classifies patients into three tiers based on complexity. Tier 1 patients (newly diagnosed, no comorbidities, blood pressure <160/100 mmHg) can complete intake, labs, and prescription within 48 hours entirely via telehealth. Tier 2 patients (established hypertension with CKD or diabetes, BP up to 180/110 mmHg) require lab results before the prescribing visit but can still be managed remotely. Tier 3 patients (BP >180/110 mmHg, hypertensive urgency features, or suspected secondary hypertension) are referred for same-day in-person evaluation before telehealth management can continue.

A 2022 systematic review in the Journal of the American Medical Association found that telehealth blood pressure management produced clinically meaningful reductions in systolic blood pressure (mean difference: 4.0 mmHg, 95% CI 2.2 to 5.9 mmHg) compared with usual care, with adherence rates similar across modalities [10]. Telehealth does not require the patient to own a Bluetooth-connected device, though self-reported blood pressure from a home cuff is acceptable documentation for titration decisions.

Most New Jersey telehealth visits for a straightforward antihypertensive prescription run $49, $89 without insurance. With commercial insurance, the copay is typically $0, $30 depending on plan design. The e-prescription is transmitted directly to the pharmacy of your choice anywhere in New Jersey.

Pharmacy Access for Losartan in New Jersey

Generic losartan potassium tablets (25 mg, 50 mg, 100 mg) are manufactured by several companies including Teva, Aurobindo, Mylan (Viatris), and others, and are stocked at pharmacies throughout New Jersey's 21 counties. GoodRx pricing as of early 2025 shows a 30-tablet supply of losartan 50 mg at roughly $4, $14 at major New Jersey chains, depending on whether you use a discount card.

Mail-order pharmacies licensed in New Jersey (including CVS Caremark, Express Scripts, and OptumRx mail-order divisions) can ship a 90-day supply for the cost of two copays under most commercial plans, making adherence cheaper over time.

503A compounding pharmacies in New Jersey are licensed by the New Jersey Board of Pharmacy and may prepare patient-specific losartan formulations, most commonly oral suspensions for pediatric patients or those with swallowing difficulties. Standard commercial losartan tablets are not available in liquid form from any major manufacturer, so a 503A compounder fills that gap legally and within state licensure requirements. Compounded losartan is not bioequivalent-tested against the branded product, and the prescriber must document a patient-specific clinical need in the order.

The New Jersey Board of Pharmacy maintains a public online license verification tool where patients can confirm that a pharmacy is actively licensed before transferring a prescription [11].

Transferring a Losartan Prescription to New Jersey

Transferring an existing losartan prescription to a New Jersey pharmacy is permitted under New Jersey pharmacy law. A retail pharmacy in New Jersey can receive a transferred prescription from an out-of-state pharmacy for a non-controlled drug like losartan. The receiving pharmacist contacts the original dispensing pharmacy directly; the patient typically does not need to take any action beyond requesting the transfer at the new pharmacy counter or via the pharmacy's app.

If you move to New Jersey with a losartan prescription written by an out-of-state provider, the prescription is valid for up to one year from the date written (for non-controlled substances) under both New Jersey law and the Uniform Prescription Drug Act provisions adopted by neighboring states. The receiving pharmacy will contact the out-of-state pharmacy to confirm remaining refills.

For patients whose prior provider is no longer accessible, a new New Jersey provider, including via telehealth, can issue a fresh prescription after a brief visit. Most telehealth platforms accept prior medical records electronically, which speeds that appointment considerably.

NJ Medicaid Prior Authorization for Losartan

NJ FamilyCare (New Jersey's Medicaid program) covers losartan for hypertension, heart failure, and diabetic nephropathy, but requires prior authorization (PA). The PA criteria generally require documentation that the patient has a covered diagnosis confirmed by an ICD-10 code (I10 for essential hypertension, I50.x for heart failure, N08 or E11.65 for diabetic nephropathy) and, in some cases, evidence that a first-line ACE inhibitor was tried and not tolerated.

The ACE inhibitor step-therapy requirement is the most common PA hurdle. Documenting ACE inhibitor intolerance due to cough (the most frequent reason) typically requires a note in the medical record specifying the symptom and the ACE inhibitor tried. A letter from the prescriber stating "Patient developed persistent dry cough on lisinopril 10 mg, discontinued after 4 weeks, switching to losartan 50 mg" satisfies most NJ FamilyCare PA reviewers [12].

PA approval typically takes 1, 3 business days through standard review. Urgent PA requests for patients with acute blood pressure elevation may be processed within 24 hours. During the PA review period, prescribers can request a 72-hour emergency supply at most retail pharmacies under NJ pharmacy law.

The American Academy of Family Physicians has stated that prior authorization processes should not delay medically necessary treatment, and their 2023 position statement calls for a maximum 72-hour turnaround on urgent PA requests for cardiovascular medications [13].

Dosing, Titration, and Monitoring After Starting Losartan

Standard practice in New Jersey and nationally follows the FDA-approved dosing schedule. Adults start at 50 mg once daily for hypertension. If blood pressure remains above target after 3 to 4 weeks, the dose moves to 100 mg once daily, which is the maximum approved dose for hypertension [4]. For heart failure, the ELITE II trial tested doses up to 150 mg/day, but current labeling caps the heart failure dose at 100 mg/day [14].

Losartan can be taken with or without food. Taking it at the same time each day, typically morning or evening, reduces missed doses. A missed dose should be taken as soon as remembered unless it is close to the next scheduled time; doubling up is not recommended.

Monitoring after initiation should include blood pressure checks at 2 and 4 weeks (home monitoring is acceptable and preferred by the 2017 ACC/AHA guideline for most patients [7]), plus a repeat basic metabolic panel at 2 to 4 weeks. Once the dose is stable and blood pressure is controlled, annual labs are sufficient for most low-risk patients; patients with CKD or baseline potassium near the upper limit of normal may need checks every 3 to 6 months.

Drug interactions worth noting: concurrent use of NSAIDs (ibuprofen, naproxen) can blunt the antihypertensive effect and worsen renal function. Potassium supplements or potassium-containing salt substitutes add hyperkalemia risk. Dual RAAS blockade, meaning combining losartan with an ACE inhibitor or aliskiren, is not recommended in most patients based on the ONTARGET trial findings [15].

Frequently Asked Questions